Catalyst Biosciences Inc

NASDAQ:CBIO   3:59:50 PM EDT
4.07
-0.07 (-1.69%)
Products

Catalyst Biosciences Receives FDA Fast Track Designation For Subcutaneous Marzaa For The Treatment Of Episodic Bleeding In Factor Vii Deficiency

Published: 06/28/2021 12:42 GMT
Catalyst Biosciences Inc (CBIO) - Catalyst Biosciences Receives FDA Fast Track Designation for Subcutaneous Marzaa for the Treatment of Episodic Bleeding in Factor Vii Deficiency.